Evidence map›Paper›PMID 36314413›Full record

ArticleHip international : the journal of clinical and experimental research on hip pathology and therapy2023

Careful patient selection together with optimal implant positioning may reduce but does not eliminate the risk of elevated serum cobalt and chrome levels following metal-on-metal hip resurfacing.

Alexander Oxblom, Håkan Hedlund, Raed Itayem, Li Felländer-Tsai, Mathias Vidgren, Ola Rolfson, Harald Brismar

Open access · hybridAbstract read
In one paragraph

Article in Hip international : the journal of clinical and experimental research on hip pathology and therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Alexander OxblomDivision of Orthopaedics and Biotechnology, CLINTEC, Karolinska Institute, Stockholm, Sweden.ORCID 0000-0002-3924-5991
Håkan HedlundDivision of Orthopaedics and Biotechnology, CLINTEC, Karolinska Institute, Stockholm, Sweden.
Raed ItayemDepartment of Orthopaedics, Institute of Clinical Sciences, Sahlgrenska Academy University of Gothenburg, Sweden.
Li Felländer-TsaiDivision of Orthopaedics and Biotechnology, CLINTEC, Karolinska Institute, Stockholm, Sweden.
Mathias VidgrenDivision of Orthopaedics and Biotechnology, CLINTEC, Karolinska Institute, Stockholm, Sweden.
Ola RolfsonDepartment of Orthopaedics, Institute of Clinical Sciences, Sahlgrenska Academy University of Gothenburg, Sweden.
Harald BrismarDivision of Orthopaedics and Biotechnology, CLINTEC, Karolinska Institute, Stockholm, Sweden.
Karolinska Institutet · SEKarolinska University Hospital · SEUniversity of Gothenburg · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundElevated serum chrome (sCr) and cobalt (sCo) concentrations are associated with local tissue adverse reactions to metal debris following metal-on-metal hip resurfacing (MoM-HR). Serum metal ions <2 µg/l are probably of little clinical relevance and a pragmatic "safe" threshold <5 µg/l has been suggested.The primary aim of this study was to evaluate if a careful selection of patients combined with optimal implant positioning could eliminate cases with "unsafe" serum metal ion levels. A secondary aim was to study the association between different risk factors and having Co and/or Cr levels >5 µg/l. PATIENTS AND

methodsThis is a retrospective, single-institution cohort study of 410 consecutive patients operated on with a Birmingham Hip Resurfacing (BHR) implant between 2001 and 2014. 288 of these had a unilateral MoM-HR, pelvic and true lateral radiographs, and a related sCo and sCr sample, and were included in the final analysis. They were allocated to either a presumed "optimal group" consisting of only men aged <60 years old, with femoral head component >48 mm diameter, and with a cup positioned within Lewinnek's safe zones, or a "suboptimal group" consisting of the remaining patients. Fisher's exact test and multiple logistic regression analyses were performed.

resultsIn the optimal group 48% (47/97) had serum metal ions >2 µg/l and 8% (8/97) >5 µg/l compared to 61% (116/191) and 18% (34/191) in the suboptimal group,

conclusionsA well oriented BHR acetabular component in a presumably "optimal" patient reduces the risk of having elevated serum metal ions but does not eliminate it. Insufficient cup anteversion seems to be the strongest associated factor of elevated serum metals.

Indexed as

Arthroplasty, Replacement, HipHip ProsthesisMetal-on-Metal Joint ProsthesesChromiumCobaltCohort StudiesHumansIonsMaleMetalsMiddle AgedPatient SelectionProsthesis DesignRetrospective StudiesChromiumCobaltIonsMetalsHip arthroplastyhip resurfacingmetal ionsmetal-on-metal

Identifiers

PMID36314413
PMCPMC10486161
OpenAlexW4307776621

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.